SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fractures. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; and iFuse-TORQ, a set of 3D-printed threaded implants designed to treat fractures of the pelvis and for minimally invasive sacroiliac joint fusion. It markets its products primarily with a direct sales force, as well as through distributors. The company was incorporated in 2008 and is headquartered in Santa Clara, California.
Earnings for SI-BONE, Inc. (SIBN)
Earnings in 2023 (TTM): $-43,336,000
According to SI-BONE, Inc.'s latest financial reports the company's current earnings (TTM) are $-43,336,000. The earnings displayed on this page is the company's Pretax Income.
Earnings history of SI-BONE, Inc.
Annual Earnings
| Year | Income Before Tax | Net Income |
|---|---|---|
| 2023 | $-43,336,000 | $-43,336,000 |
| 2022 | $-61,256,000 | $-62,903,000 |
| 2021 | $-56,572,000 | $-60,128,000 |
| 2020 | $-43,697,000 | $-48,542,000 |
| 2019 | $-38,403,000 | $-42,576,000 |
| 2018 | $-17,453,000 | $-17,453,000 |
| 2017 | $-23,039,000 | $-23,039,000 |
| 2016 | $-20,589,000 | $-20,589,000 |
| 2015 | $-28,154,000 | $-28,154,000 |
| 2014 | $-27,804,000 | $-27,806,000 |
| 2013 | $-6,144,000 | $-6,154,000 |
| 2012 | $-10,903,000 | $-10,903,000 |